GlassScriptPhysician profile
Anthony J Schena
NPI 1952398174
$56,618.65
in general payments reported to CMS, 2019-2025
21 companies · $153 in 2025
The $153 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,836 · 2020: $46K · 2021: $722 · 2022: $6,942 · 2023: $617 · 2024: $351 · 2025: $153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,121.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,120.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Anika Therapeutics, INC. | $51,773.28 | 2020-2022 | |
| Stryker Corporation | $915.66 | 2019-2025 | Mako |
| Arthrex, INC. | $846.48 | 2019 | |
| Smith+Nephew, INC. | $508.03 | 2019-2024 | N/A, Evos |
| Pacira Pharmaceuticals Incorporated | $486.27 | 2020-2025 | Iovera, Zilretta |
| Heron Therapeutics, INC. | $332.89 | 2022-2023 | Zynrelef |
| Arteriocyte Medical Systems, INC. | $260.55 | 2022 | |
| Depuy Synthes Products, INC. | $225.00 | 2019 | |
| Ferring Pharmaceuticals INC. | $218.10 | 2019-2022 | |
| Bioventus LLC | $213.14 | 2019-2023 | Exogen Ultrasound Bone Healing System, Durolane |
| Orthofix Medical, INC. | $168.47 | 2021-2023 | Physio-Stim |
| Wright Medical Technology, INC. | $166.33 | 2019 | |
| Pacira Therapeutics, INC. | $159.44 | 2019-2021 | |
| Avanos Medical | $116.79 | 2021 | |
| Depuy Synthes Sales INC. | $88.29 | 2019-2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fidia Pharma USA INC. | $40.84 | 2019 | |
| Djo, LLC | $34.99 | 2019 | |
| Kairos Surgical INC | $26.93 | 2024 | |
| Abbott Laboratories | $25.23 | 2024 | Proclaim |
| Pfizer INC. | $11.94 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$134,852.77 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Schena listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.